General Thoracic and Cardiovascular Surgery

, Volume 58, Issue 4, pp 182–185 | Cite as

Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer

  • Yasushi ShintaniEmail author
  • Mitsunori Ohta
  • Teruo Iwasaki
  • Naoki Ikeda
  • Emiko Tomita
  • Kunimitsu Kawahara
  • Yuko Ohno
Original Article



Postoperative acute exacerbation (AE) of usual interstitial pneumonia (UIP) is a serious complication in the surgical treatment for primary lung cancer combined with UIP. The purpose of this study was to determine the predictors of AE of UIP after a major lung resection.


We retrospectively collected data for 40 patients who had been operated on for lung cancer and were diagnosed as UIP based on postoperative histopathological diagnosis. We then evaluated some predictive factors related to the AE of UIP.


The incidence of postoperative AE of UIP was 15% (6/40 patients). No correlation between patients who developed AE of UIP and those who did not, in terms of preoperative C-reactive protein, white blood cell count, percentage lymphocytes, forced expiratory volume in 1 s, percentage total lung capacity, percentage diffusing capacity of lung for carbon monoxide, and the alveolar partial pressures of oxygen and carbon dioxide. Preoperative serum lactate dehydrogenase (LDH) and serum KL-6 were significantly higher and the percent vital capacity (%VC) was significantly lower in patients who developed AE of UIP than in those who did not. Furthermore, recursive descent partition analysis revealed that %VC (<80.6%) and LDH (≥241 IU/l) could distinguish patients with AE from those without AE.


Preoperative %VC plus serum LDH values were considered the predictive factors for AE of UIP after surgery for lung cancer.

Key words

Lung cancer Usual interstitial pneumonia Acute exacerbation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study. Am J Respir Crit Care Med 2000;161:5–8.PubMedGoogle Scholar
  2. 2.
    Kawasaki H, Nagai K, Yokose T, Yoshida J, Nishimura M, Takahashi K, et al. Clinicopathological characteristics of surgically resected lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 2001;76:53–57.CrossRefPubMedGoogle Scholar
  3. 3.
    Ginsberg RJ, Hill LD, Eagan RT, Thomas P, Mountain CF, Deslauriers J, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983;86:654–658.PubMedGoogle Scholar
  4. 4.
    Wada H, Nakamura T, Nakamoto K, Maeda M, Watanabe Y. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg 1998;115:70–73.CrossRefPubMedGoogle Scholar
  5. 5.
    Ferguson MK, Reeder LB, Mick R. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg 1995;109:275–283.CrossRefPubMedGoogle Scholar
  6. 6.
    Koizumi K, Hirata T, Hirai K, Mikami I, Okada D, Yamagishi S, et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg 2004;10:340–346.PubMedGoogle Scholar
  7. 7.
    Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 2004;10:3291–3300.CrossRefPubMedGoogle Scholar
  8. 8.
    Kumar P, Goldstraw P, Yamada K, Nicholson AG, Wells AU, Hansell DM, et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 2003;125:1321–1327.CrossRefPubMedGoogle Scholar
  9. 9.
    Carrington CB, Gaensler EA, Coutu RE, FitzGerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801–809.PubMedCrossRefGoogle Scholar
  10. 10.
    Izumi Y, Gika M, Kohno M, Kikuchi K, Kobayashi K. Surgical resection for lung cancer patients with idiopathic interstitial pneumonia. Lung Cancer 1997;18:113–114.CrossRefGoogle Scholar
  11. 11.
    DeRemee RA. Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis. JAMA 1968;204:1193–1195.CrossRefPubMedGoogle Scholar
  12. 12.
    Muraoka M, Tagawa T, Akamine S, Oka T, Tsuchiya T, Araki M, et al. Acute interstitial pneumonia following surgery for primary lung cancer. Eur J Cardiothorac Surg 2006;30:657–662.CrossRefPubMedGoogle Scholar
  13. 13.
    Ishii H, Mukae H, Kadota J, Kaida H, Nagata T, Abe K, et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003;58:121–128.CrossRefGoogle Scholar
  14. 14.
    Sakuma T, Takahashi K, Ohya N, Usuda K, Handa M. Serum KL-6, a novel mucin-like glycoprotein, as an indicator of interstitial pneumonitis following lobectomy. Surg Today 1999;29:121–128.CrossRefPubMedGoogle Scholar
  15. 15.
    Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1680–1684.PubMedGoogle Scholar
  16. 16.
    Yuksel M, Ozyurtkan MO, Bostanci K, Ahiskari R, Kodalli N. Acute exacerbation of interstitial fibrosis after pulmonary resection. Ann Thorac Surg 2006;82:336–338.CrossRefPubMedGoogle Scholar
  17. 17.
    Minegishi Y, Takenaka K, Mizutani H, Sudoh J, Noro R, Okano T, et al. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. Intern Med 2009;48:665–672.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Association for Thoracic Surgery 2010

Authors and Affiliations

  • Yasushi Shintani
    • 1
    Email author
  • Mitsunori Ohta
    • 1
  • Teruo Iwasaki
    • 1
  • Naoki Ikeda
    • 1
  • Emiko Tomita
    • 1
  • Kunimitsu Kawahara
    • 2
  • Yuko Ohno
    • 3
  1. 1.Department of Thoracic Surgery, Osaka Prefectural Hospital OrganizationPrefectural Medical Center for Respiratory and Allergic DiseaseHabikino, OsakaJapan
  2. 2.Department of Pathology, Osaka Prefectural Hospital OrganizationPrefectural Medical Center for Respiratory and Allergic DiseaseOsakaJapan
  3. 3.Department of Mathematical Health ScienceOsaka University Graduate School of MedicineOsakaJapan

Personalised recommendations